- Home
- YOU vs XENE Comparison
YOU vs XENE Comparison
Compare YOU & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YOU
- XENE
- Stock Information
- Founded
- YOU 2010
- XENE 1996
- Country
- YOU United States
- XENE Canada
- Employees
- YOU 3698
- XENE N/A
- Industry
- YOU Computer Software: Prepackaged Software
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- YOU Technology
- XENE Health Care
- Exchange
- YOU Nasdaq
- XENE Nasdaq
- Market Cap
- YOU 2.5B
- XENE 3.0B
- IPO Year
- YOU 2021
- XENE 2014
- Fundamental
- Price
- YOU $26.23
- XENE $39.83
- Analyst Decision
- YOU Buy
- XENE Strong Buy
- Analyst Count
- YOU 6
- XENE 10
- Target Price
- YOU $31.83
- XENE $57.30
- AVG Volume (30 Days)
- YOU 2.7M
- XENE 382.6K
- Earning Date
- YOU 11-07-2024
- XENE 11-12-2024
- Dividend Yield
- YOU 1.91%
- XENE N/A
- EPS Growth
- YOU 2686.35
- XENE N/A
- EPS
- YOU 0.86
- XENE N/A
- Revenue
- YOU $735,183,000.00
- XENE N/A
- Revenue This Year
- YOU $25.60
- XENE N/A
- Revenue Next Year
- YOU $15.27
- XENE $1,600.08
- P/E Ratio
- YOU $30.53
- XENE N/A
- Revenue Growth
- YOU 28.78
- XENE N/A
- 52 Week Low
- YOU $16.05
- XENE $28.20
- 52 Week High
- YOU $38.88
- XENE $50.99
- Technical
- Relative Strength Index (RSI)
- YOU 31.53
- XENE 39.07
- Support Level
- YOU $26.30
- XENE $41.42
- Resistance Level
- YOU $28.75
- XENE $44.61
- Average True Range (ATR)
- YOU 1.45
- XENE 1.53
- MACD
- YOU -1.20
- XENE -0.36
- Stochastic Oscillator
- YOU 3.84
- XENE 2.99
About YOU Clear Secure Inc.
Clear Secure Inc is an identity company making experiences safer and easier digitally and physically. It is involved in the creation of a frictionless travel experience while enhancing security. Its secure identity platform uses biometrics to automate the identity verification process through lanes in airports which helps to make the travel experience safe and easy.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.